GlassScriptPhysician profile
Darby Todd
NPI 1457817173
$9,415.92
in general payments reported to CMS, 2019-2025
50 companies · $1,678 in 2025
The $1,678 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $674 · 2023: $3,350 · 2024: $3,713 · 2025: $1,678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,722 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,721.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,714.04 | 2022-2025 | |
| Cequr Corporation | $876.53 | 2023-2025 | Cequr Simplicity |
| Lilly USA, LLC | $717.08 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $605.70 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $523.44 | 2022-2025 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $429.30 | 2022-2025 | |
| Glaxosmithkline, LLC. | $390.42 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Sumitomo Pharma America, INC. | $352.54 | 2023-2025 | Gemtesa |
| Astrazeneca Pharmaceuticals LP | $341.34 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $330.75 | 2023-2025 | Jardiance, Synjardy, Spiriva Respimat |
| Antares Pharma, INC. | $273.71 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Pfizer INC. | $270.00 | 2023-2025 | |
| Amgen INC. | $265.62 | 2022-2024 | Repatha, Otezla |
| Otsuka America Pharmaceutical, INC. | $195.77 | 2022-2025 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $162.37 | 2022-2023 | Livalo, Seglentis |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $159.08 | 2024-2025 | Loreev Xr |
| Astellas Pharma US INC | $148.78 | 2023-2024 | Veozah, Myrbetriq |
| Idorsia Pharmaceuticals US INC | $144.66 | 2023-2024 | Quviviq |
| Exact Sciences Corporation | $141.47 | 2023-2025 | Cologuard Collection Kit |
| Esperion Therapeutics, INC. | $115.24 | 2022-2025 | Nexletol |
| Takeda Pharmaceuticals U.S.A., INC. | $107.00 | 2022-2023 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $101.51 | 2023-2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $90.20 | 2023-2024 | Xarelto |
| Daiichi Sankyo INC. | $67.28 | 2023 | Injectafer |
| Paratek Pharmaceuticals, INC. | $63.13 | 2022-2025 | Nuzyra |
| Tolmar, INC. | $60.70 | 2024 | |
| Xeris Pharmaceuticals, INC. | $57.65 | 2023-2025 | Gvoke Hypopen |
| Ironwood Pharmaceuticals, INC | $57.35 | 2024 | |
| Merck Sharp & Dohme LLC | $54.71 | 2023-2024 | Verquvo, Belsomra, Vaxneuvance |
| Axsome Therapeutics, INC. | $53.55 | 2025 | Auvelity |
| Novartis Pharmaceuticals Corporation | $48.18 | 2023-2024 | |
| Supernus Pharmaceuticals, INC. | $42.42 | 2023-2024 | Xyosted, Qelbree, Qelbree |
| Medicure Pharma INC. | $41.50 | 2024-2025 | Zypitamag |
| Verity Pharmaceuticals INC. | $37.25 | 2024-2025 | Tlando |
| Biohaven Pharmaceutical Holding Company LTD. | $35.63 | 2022 | |
| Alkermes, INC. | $35.35 | 2023 | Lybalvi, Aristada |
| Emmaus Medical, INC. | $34.15 | 2023-2024 | Endari |
| Insulet Corporation | $33.30 | 2023 | Omnipod |
| E.R. Squibb & Sons, L.L.C. | $32.84 | 2023-2024 | Eliquis |
| Sunovion Pharmaceuticals INC. | $29.60 | 2022 | |
| Edwards Lifesciences Corporation | $25.44 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Halozyme INC | $24.81 | 2023 | |
| Noven Therapeutics, LLC | $21.63 | 2024 | Xelstrym |
| Phathom Pharmaceuticals, INC. | $18.50 | 2023 | Voquezna |
| Heartflow, INC. | $17.96 | 2023 | Ffrct |
| Corcept Therapeutics | $15.28 | 2024 | Korlym |
| Nestle Healthcare Nutrition INC. | $13.72 | 2023 | |
| Hikma Pharmaceuticals USA | $13.25 | 2024 | Ryaltris |
| Organon LLC | $12.10 | 2025 | Nexplanon |
| Teva Pharmaceuticals USA, INC. | $12.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darby Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.